Hutchinson Matthew H, Chase Howard A
Department of Chemical Engineering, University of Cambridge, UK.
Biotechnol Prog. 2006 Jul-Aug;22(4):1187-93. doi: 10.1021/bp060055q.
This work describes the integration of expanded bed adsorption (EBA) and adsorptive protein refolding operations in an intensified process used to recover purified and biologically active proteins from inclusion bodies expressed in E. coli. Delta(5)-3-Ketosteroid isomerase with a C-terminal hexahistidine tag was expressed as inclusion bodies in the cytoplasm of E. coli. Chemical extraction was used to disrupt the host cells and simultaneously solubilize the inclusion bodies, after which EBA utilizing immobilized metal affinity interactions was used to purify the polyhistidine-tagged protein. Adsorptive refolding was then initiated in the column by changing the denaturant concentration in the feed stream from 8 to 0 M urea. Three strategies were tested for performing the refolding step in the EBA column: (i) the denaturant was removed using a step change in feed-buffer composition, (ii) the denaturant was gradually removed using a gradient change in feed-buffer composition, and (iii) the liquid flow direction through the column was reversed and adsorptive refolding performed in the packed bed. Buoyancy-induced mixing disrupted the operation of the expanded bed when adsorptive refolding was performed using either a step change or a rapid gradient change in feed-buffer composition. A shallow gradient reduction in denaturant concentration of the feed stream over 30 min maintained the stability of the expanded bed during adsorptive refolding. In a separate experiment, buoyancy-induced mixing was completely avoided by performing refolding in a settled bed, which achieved comparable yields to refolding in an expanded bed but required a slightly more complex process. A total of 10% of the available KSI-(His(6)) was recovered as biologically active and purified protein using the described purification and refolding process, and the yield was further increased to 19% by performing a second iteration of the on-column refolding operation. This process should be applicable for other polyhistidine tagged proteins and is likely to have the greatest benefit for proteins that tend to aggregate when refolded by dilution.
这项工作描述了在一个强化过程中扩展床吸附(EBA)与吸附性蛋白质复性操作的整合,该强化过程用于从大肠杆菌中表达的包涵体中回收纯化的、具有生物活性的蛋白质。带有C末端六组氨酸标签的δ(5)-3-酮甾体异构酶在大肠杆菌细胞质中表达为包涵体。采用化学萃取法破坏宿主细胞并同时溶解包涵体,之后利用固定化金属亲和相互作用的EBA来纯化带有多组氨酸标签的蛋白质。然后通过将进料流中变性剂浓度从8 M尿素改变为0 M尿素,在柱中启动吸附性复性。测试了三种在EBA柱中进行复性步骤的策略:(i)通过进料缓冲液组成的阶跃变化去除变性剂;(ii)通过进料缓冲液组成的梯度变化逐渐去除变性剂;(iii)使通过柱的液体流动方向反向,并在填充床中进行吸附性复性。当使用进料缓冲液组成的阶跃变化或快速梯度变化进行吸附性复性时,浮力诱导的混合会破坏扩展床的操作。在30分钟内对进料流变性剂浓度进行浅梯度降低可在吸附性复性期间维持扩展床的稳定性。在另一个实验中,通过在沉降床中进行复性完全避免了浮力诱导的混合,沉降床复性获得的产量与扩展床复性相当,但过程稍复杂一些。使用所述的纯化和复性过程,总共10%的可用KSI-(His(6))作为具有生物活性的纯化蛋白质被回收,通过在柱上复性操作进行第二轮迭代,产量进一步提高到19%。该过程应适用于其他带有多组氨酸标签的蛋白质,对于通过稀释复性时易于聚集的蛋白质可能具有最大益处。